Tapentadol, a novel opioid medication, represents a important advancement in the management of moderate to severe acute pain. Differing from traditional opioids, it exhibits a dual process of action, acting as both a mu-opioid receptor binder and a noradrenaline uptake blocker. This blend is thought to contribute to a possibly reduced occurrence… Read More